SCHEMBL13624016

SCHEMBL13624016

COc1cc(C2CC(=O)C=CN2CC(=O)c2ccccc2)ccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 6/20 0.43
HPGD P15428 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GRIN2B Q13224 2/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
BLM P54132 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
FLT4 P35916 1/20 0.35
KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13624040 0.83 GRIN2B (0.48) P2RX7NPC1RAB9AGRIN2BMEN1
SCHEMBL13623996 0.81 P2RX7 (0.45) P2RX7HPGDRAB9ASMN1; SMN2GRIN2B
SCHEMBL13624010 0.80 P2RX7 (0.39) P2RX7GRIN2BPOLBMEN1ALDH1A1
SCHEMBL13634012 0.79 P2RX7 (0.45) P2RX7MEN1ALDH1A1KMT2AMAPT
SCHEMBL10200297 0.73 ALDH1A1 (0.42) P2RX7RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL13624015 0.70 ALDH1A1 (0.36) P2RX7GRIN2BALDH1A1KMT2A
SCHEMBL13624018 0.70 PIK3CD (0.45) P2RX7HPGDRAB9ASMN1; SMN2ALDH1A1
SCHEMBL13624017 0.66 KMT2A (0.40) HPGDNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL6378445 0.63 KCNK3 (0.53) HPGDNPC1RAB9AMEN1ALDH1A1
SCHEMBL4349642 0.61 P2RX7 (0.53) P2RX7POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622489-B2 Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl)-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-dihydro-1N-pyrrol-1-carboxamide MERCK & CO., INC. (US) 2009-11-24 US disclosed